Table 2. Cardiac and non-cardiac gene processes activated by Tbx5, Gata4, and Myocd.
Gene ontology name | T | G | M | T+G | G+M | T+M | T+G+M |
Cardiac | (permute P value) | ||||||
Wnt receptor signaling pathway | 0.004* | N | N | 0.63 | 1.0 | 0.602 | 0.802 |
Circulation | 0.54 | 0.016* | 0* | 0.01* | 0.015* | 0* | 0* |
Contractile fiber | N | N | 0.01* | N | N | 0.001* | 0.002* |
Muscle contraction | N | N | 0.002* | 0.767 | 0.126 | 0* | 0.006* |
Muscle development | 0.213 | 0.803 | 0.016* | 1.0 | 0.469 | 0.077 | 0.032* |
Myofibril | N | N | 0.005* | N | N | 0* | 0.006* |
Sarcomere | N | N | 0.002* | N | N | 0* | 0.003* |
Structural constituent of cytoskeleton | N | N | 0.043* | N | 0.518 | 0.131 | 0.013* |
Muscle cell differentiation | N | N | 0.019* | 0.089 | 0.036* | 0.007* | 0.041* |
Striated muscle contraction | N | N | N | N | N | 0* | 0* |
Regulation of heart contraction | N | N | N | N | N | N | 0* |
Structural constituent of muscle | N | N | N | N | N | N | 0.003* |
Glucose metabolism | N | 0.115 | 0.586 | 0.083 | 0.428 | 0.417 | 0.009* |
Fatty acid oxidation | N | 0.001* | N | 0* | 0.02* | 0.039* | 0.046* |
GO terms with permute p<0.05 and a nested gene change number ≥4 were considered to be significantly activated. GOs with a nested gene change number <4 were shown as “N”. GO terms that were both activated and inhibited were excluded. T, Tbx5; G, Gata4; M, Myocd.